{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T20:54:36Z","timestamp":1766609676256},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Funding from The Jikei University School of Medicine","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1481-z","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T20:19:58Z","timestamp":1512677998000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis"],"prefix":"10.1186","volume":"19","author":[{"given":"Ken","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyasu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Ukichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daitaro","family":"Kurosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"1481_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med."},{"issue":"Suppl 1","key":"1481_CR2","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/ana.410370709","volume":"37","author":"MC Dalakas","year":"1995","unstructured":"Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol. 1995;37 Suppl 1:S74\u201386.","journal-title":"Ann Neurol."},{"key":"1481_CR3","doi-asserted-by":"crossref","unstructured":"Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndrome. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York. 2006;1335\u201383.","DOI":"10.1016\/B978-012595961-2\/50037-8"},{"key":"1481_CR4","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1002\/art.27704","volume":"62","author":"K Yoshida","year":"2010","unstructured":"Yoshida K, Kurosaka D, Joh K, et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging. Arthritis Rheum. 2010;62:3751\u20139.","journal-title":"Arthritis Rheum."},{"key":"1481_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3899\/jrheum.160763","volume":"44","author":"K Noda","year":"2017","unstructured":"Noda K, Yoshida K, Ukichi T, Furuya K, Hirai K, Kingetsu I, et al. Myalgia in patients with dermatomyositis and polymyositis is attributable to fasciitis rather than myositis: a retrospective study of 32 patients who underwent histopathological examinations. J Rheumatol. 2017;44:482\u20137.","journal-title":"J Rheumatol."},{"key":"1481_CR6","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.39798","volume":"68","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Nishioka M, Matsushima S, Joh K, Oto Y, Yoshiga M, et al. Brief report: power Doppler ultrasonography for detection of increased vascularity in the fascia: a potential early diagnostic tool in fasciitis of dermatomyositis. Arthritis Rheumatol. 2016;68:2986\u201391.","journal-title":"Arthritis Rheumatol."},{"key":"1481_CR7","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","volume":"58","author":"C Grundtman","year":"2008","unstructured":"Grundtman C, Tham E, Ulfgren AK, Lundberg IE. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum. 2008;58:3224\u201338.","journal-title":"Arthritis Rheum."},{"key":"1481_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-3-2","volume":"3","author":"K Nagaraju","year":"2006","unstructured":"Nagaraju K, Rider LG, Fan C, Chen YW, Mitsak M, Rawat R, et al. Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis. 2006;3:2.","journal-title":"J Autoimmune Dis."},{"key":"1481_CR9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","volume":"83","author":"TE Lloyd","year":"2014","unstructured":"Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 2014;83:426\u201333.","journal-title":"Neurology."},{"issue":"Suppl 1","key":"1481_CR10","doi-asserted-by":"crossref","first-page":"I61","DOI":"10.1136\/ard.58.2008.i61","volume":"58","author":"G Harriman","year":"1999","unstructured":"Harriman G, Harper LK, Schaible TF. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment. Ann Rheum Dis. 1999;58 Suppl 1:I61\u20134.","journal-title":"Ann Rheum Dis."},{"key":"1481_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 1990;27:343\u201356.","journal-title":"Ann Neurol."},{"key":"1481_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O\u2019Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439\u201342.","journal-title":"Nature."},{"key":"1481_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249\u201357.","journal-title":"Nature."},{"key":"1481_CR14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","volume":"74","author":"E Noguchi","year":"2017","unstructured":"Noguchi E, Uruha A, Suzuki S, Hamanaka K, Ohnuki Y, Tsugawa J, et al. Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol. 2017;74:992\u20139.","journal-title":"JAMA Neurol."},{"key":"1481_CR15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","volume":"9","author":"S Ramakrishnan","year":"2014","unstructured":"Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol. 2014;9:142\u201360.","journal-title":"J Neuroimmune Pharmacol."},{"key":"1481_CR16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature."},{"key":"1481_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568010053622830","volume":"4","author":"A Naldini","year":"2005","unstructured":"Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy. 2005;4:3\u20138.","journal-title":"Curr Drug Targets Inflamm Allergy."},{"key":"1481_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","volume":"8","author":"S Konisti","year":"2012","unstructured":"Konisti S, Kiriakidis S, Paleolog EM. Hypoxia\u2013a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol. 2012;8:153\u201362.","journal-title":"Nat Rev Rheumatol."},{"key":"1481_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.11473","volume":"50","author":"CL Peters","year":"2004","unstructured":"Peters CL, Morris CJ, Mapp PI, Blake DR, Lewis CE, Winrow VR. The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum. 2004;50:291\u20136.","journal-title":"Arthritis Rheum."},{"key":"1481_CR20","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s10067-007-0605-2","volume":"26","author":"YA Lee","year":"2007","unstructured":"Lee YA, Kim JY, Hong SJ, Lee SH, Yoo MC, Kim KS, et al. Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients. Clin Rheumatol. 2007;26:2023\u20139.","journal-title":"Clin Rheumatol."},{"key":"1481_CR21","first-page":"646","volume":"26","author":"CH Jeon","year":"2008","unstructured":"Jeon CH, Ahn JK, Chai JY, Kim HJ, Bae EK, Park SH, et al. Hypoxia appears at pre-arthritic stage and shows co-localization with early synovial inflammation in collagen induced arthritis. Clin Exp Rheumatol. 2008;26:646\u20138.","journal-title":"Clin Exp Rheumatol."},{"key":"1481_CR22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","volume":"10","author":"A Marrelli","year":"2011","unstructured":"Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, et al. Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun Rev. 2011;10:595\u20138.","journal-title":"Autoimmun Rev."},{"key":"1481_CR23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051165","volume":"99","author":"S Kuru","year":"2000","unstructured":"Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G. Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol. 2000;99:585\u20138.","journal-title":"Acta Neuropathol."},{"key":"1481_CR24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","volume":"40","author":"I Lundberg","year":"1997","unstructured":"Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997;40:865\u201374.","journal-title":"Arthritis Rheum."},{"key":"1481_CR25","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","volume":"17","author":"S Yoshida","year":"1997","unstructured":"Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol. 1997;17:4015\u201323.","journal-title":"Mol Cell Biol."},{"key":"1481_CR26","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","volume":"67","author":"M Dastmalchi","year":"2008","unstructured":"Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis. 2008;67:1670\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1481_CR27","doi-asserted-by":"crossref","first-page":"179180","DOI":"10.1155\/2014\/179180","volume":"2014","author":"AM Brunasso","year":"2014","unstructured":"Brunasso AM, Abererb W, Massone C. New onset of dermatomyositis\/polymyositis during anti-TNF-\u03b1 therapies: a systematic literature review. Scientific World Journal. 2014;2014:179180.","journal-title":"Scientific World Journal."},{"key":"1481_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","volume":"50","author":"GJ Hengstman","year":"2003","unstructured":"Hengstman GJ, van den Hoogen FH, Barrera P, Netea MG, Pieterse A, van de Putte LB, et al. Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol. 2003;50:10\u20135.","journal-title":"Eur Neurol."},{"key":"1481_CR29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2005.048744","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Schwartzman S, Kagen LJ. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients. Ann Rheum Dis. 2006;65:1233\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1481_CR30","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10067-006-0325-z","volume":"26","author":"S Dold","year":"2007","unstructured":"Dold S, Justiniano ME, Marquez J, Espinoza LR. Treatment of early and refractory dermatomyositis with infliximab: a report of two cases. Clin Rheumatol. 2007;26:1186\u20138.","journal-title":"Clin Rheumatol."},{"key":"1481_CR31","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1007\/s00296-011-2220-4","volume":"32","author":"JK Park","year":"2012","unstructured":"Park JK, Yoo HG, Ahn DS, Jeon HS, Yoo WH. Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab. Rheumatol Int. 2012;32:3587\u201390.","journal-title":"Rheumatol Int."},{"key":"1481_CR32","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00296-012-2653-4","volume":"33","author":"D Chen","year":"2013","unstructured":"Chen D, Wang XB, Zhou Y, Zhu XC. Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review. Rheumatol Int. 2013;33:2455\u20138.","journal-title":"Rheumatol Int."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1481-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T13:41:14Z","timestamp":1570455674000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1481-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1481-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"272"}}